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Introduction
Kawasaki Disease (KD) and Henoch Schönlein Purpura
(HSP) are paediatric vasculitides that can lead to signifi-
cant morbidity. Evidence-based guidelines are sparse and
management is mostly based on physician experience.
Consequently, treatment regimens differ throughout
Europe. In 2012, a European initiative called SHARE
(Single Hub and Access point for paediatric Rheumatology
in Europe) was launched to optimize and disseminate
guidelines for diagnosis and management for children and
young adults with paediatric rheumatic diseases (PRD)
such as KD and HSP within Europe.
Objectives
To provide evidence-based recommendations for diagnosis
and treatment of paediatric vasculitides, specifically KD
and HSP.
Methods
Evidence based recommendations were developed using
evidence drawn from systematic reviews of the literature.
An expert committee was formed consisting of paediatric
rheumatologists from across Europe with expertise in
vasculitis. Preliminary statements regarding recommenda-
tions on diagnosis and treatment of KD and HSP were
developed. These recommendations were evaluated by the
expert committee using an online survey. Those with less
than 80% agreement in the online survey were reformu-
lated. Subsequently, all recommendations were discussed
at a consensus meeting in Genoa (Italy) in March 2014
using the nominal group technique [1]. Recommendations
were accepted if more than 80% agreement was reached.
Results
Evidence supporting recommendations for diagnosis and
treatment was extracted from the literature. Subsequently,
53 statements on diagnosis and treatment were formulated
based on this evidence and expert opinion and were evalu-
ated in an online survey. After discussion of the state-
ments at the consensus meeting, 29 recommendations for
KD and 15 recommendations for HSP were accepted with
more than 80% agreement during the meeting. Topics
covered were criteria for diagnosis, referral of patients,
clinical symptoms, useful laboratory investigations,
imaging techniques and treatment.
Conclusion
The SHARE initiative provides recommendations for diag-
nosis and treatment of paediatric vasculitides and thereby
facilitates improvement and uniformity of care for patients
throughout Europe. Currently, similar processes are
ongoing to add additional recommendations on diagnosis
and treatment where consensus to date has not been
reached, as well as recommendations regarding the holistic
care of patients. As a final result, SHARE will provide
standards of minimal care for different PRDs, including
KD and HSP, as well as more rare vasculitides (PAN,
GPA, MPA, EGPA and TA).
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